Basic information Uses Safety Supplier Related
ChemicalBook >  Product Catalog >  Pharmaceutical intermediates >  Heterocyclic compound >  Pyridine compound >  Methylpyridine >  3,5-DIBROMO-1-METHYL-1H-PYRIDIN-2-ONE

3,5-DIBROMO-1-METHYL-1H-PYRIDIN-2-ONE

Basic information Uses Safety Supplier Related

3,5-DIBROMO-1-METHYL-1H-PYRIDIN-2-ONE Basic information

Product Name:
3,5-DIBROMO-1-METHYL-1H-PYRIDIN-2-ONE
Synonyms:
  • 3,5-DIBROMO-1-METHYL-1H-PYRIDIN-2-ONE
  • 3,5-DIBROMO-1-METHYLPYRIDIN-2(1H)-ONE
  • 3,5-DIBROMOPYRIDINE-2-OL, 98+%
  • 3,5-dibroMo-1-Methyl-1,2-dihydropyridin-2-one
  • 3,5-dibroMo-1-Methyl-2-pyridone
  • 3,5-dibromo-1-methyl-2(1H)-Pyridinone
  • N-naphthalen-2-yl-5-oxopyrrolidine-2-carboxamide
  • 3,5-Dibromo-1-methylpyridin-2-one
CAS:
14529-54-5
MF:
C6H5Br2NO
MW:
266.92
Mol File:
14529-54-5.mol
More
Less

3,5-DIBROMO-1-METHYL-1H-PYRIDIN-2-ONE Chemical Properties

Melting point:
182 °C
Boiling point:
259.4±40.0 °C(Predicted)
Density 
2.130±0.06 g/cm3(Predicted)
storage temp. 
Sealed in dry,Room Temperature
pka
-3.58±0.62(Predicted)
Appearance
Off-white to gray Solid
InChI
InChI=1S/C6H5Br2NO/c1-9-3-4(7)2-5(8)6(9)10/h2-3H,1H3
InChIKey
AOJAJTJZSBVNPU-UHFFFAOYSA-N
SMILES
C1(=O)N(C)C=C(Br)C=C1Br
More
Less

3,5-DIBROMO-1-METHYL-1H-PYRIDIN-2-ONE Usage And Synthesis

Uses

3,5-Dibromo-1-methylpyridine-2(1H)-one is a ketone organic compound that can be used as a pharmaceutical intermediate.

Synthesis

13472-81-6

74-88-4

14529-54-5

General procedure for the synthesis of 3,5-dibromo-1-methylpyridin-2(1H)-one from 3,5-dibromo-2-hydroxypyridine and iodomethane: 3,5-dibromo-1H-pyridin-2-one (5 g, 19.8 mmol) was dissolved in DMF (170 mL), K2CO3 (6.01 g, 43.5 mmol) was added and the suspension was stirred for 15 min. Subsequently, MeI (1.36 mL, 21.8 mmol) was added dropwise to the reaction system and the reaction was stirred at room temperature for 18 hours. After completion of the reaction, water (200 mL) was added to the mixture and the aqueous layer was extracted with EtOAc (3 x 200 mL). The organic layers were combined, dried with Na2SO4, filtered and concentrated under reduced pressure. The resulting solid was ground with Et2O to give 3,5-dibromo-1-methylpyridin-2(1H)-one (2 g). The filtrate was evaporated under reduced pressure and the residue was ground with Et2O to give a second product (2.0 g). The filtrate was further concentrated and purified by fast chromatography on silica gel, using a solvent mixture of EtOAc and hexane as eluent, to give finally 3,5-dibromo-1-methylpyridin-2(1H)-one (4.5 g total, 85% yield). The product was characterized by 1H NMR (500 MHz, CDCl3): δ 7.78 (d, J=2.5 Hz, 1H), 7.42 (d, J=2.5 Hz, 1H), 3.59 (s, 3H). Mass spectra (ESI) showed [M+H]+ peaks of 266.01, 267.99, 269.99.

References

[1] Patent: WO2017/24412, 2017, A1. Location in patent: Page/Page column 65
[2] Patent: US2008/153834, 2008, A1. Location in patent: Page/Page column 20-21
[3] Patent: WO2008/33858, 2008, A2. Location in patent: Page/Page column 127-128
[4] Patent: WO2008/33858, 2008, A2. Location in patent: Page/Page column 127-128

3,5-DIBROMO-1-METHYL-1H-PYRIDIN-2-ONESupplier

Changzhou Kangrui Pharmaceutical Technology Co., Ltd. Gold
Tel
+86-0519-85485169 +86-13961161173
Email
sales@kangruipharm.com
Beijing Ouhe Technology Co., Ltd
Tel
010-010-82967028 13522913783
Email
2355560935@qq.com
Tetranov Biopharm
Tel
13526569071
Email
sales@leadmedpharm.com
Adamas Reagent, Ltd.
Tel
400-6009262 16621234537
Email
chenyj@titansci.com
Accela ChemBio Co.,Ltd.
Tel
021-50795510 4000665055
Email
sales@accelachem.com